News
Research and trial news from journals we track.
Top Stories
Ranked by reader clicks and relevance, last 14 days.
CSCO and ASCO Joint Guideline for Recurrent and Metastatic Nasopharyngeal Carcinoma
Journal of clinical oncology : official journal of the American Society of Clinical OncologyJiang et alAccelerated Partial-Breast Versus Whole-Breast Irradiation in Low-Risk Invasive Breast Cancer
Journal of clinical oncology : official journal of the American Society of Clinical OncologyMeduri et alPhase III DIAMOND-2 Trial: Dirozalkib vs Crizotinib in Advanced ALK-Positive NSCLC
Cancer communications (London, England)Liu et alUpdated CAP-ASCP Guideline on HER2 Testing in Advanced Gastroesophageal Adenocarcinoma
Archives of pathology & laboratory medicineBartley et alMultidisciplinary Stage III NSCLC Management in the Immunotherapy Era
JTO clinical and research reportsGallina et al
Clinical Trials
- BMC MedicineDeng et alIllustration
Optimal Surgical Margin in Hepatocellular Carcinoma After HAIC Conversion Therapy

- JAMA surgeryLinderman et alIllustration
SBRT vs Sublobar Resection for Stage IA NSCLC: Causal Inference Analysis in SEER-Medicare

- BloodBaljevic et alIllustration
Etentamig (Investigational) in Triple-Class-Exposed Relapsed/Refractory Multiple Myeloma

Real-World Studies
- Therapeutic advances in urologyKosola et alIllustration
Cabozantinib Starting Dose in Metastatic Renal Cell Carcinoma

- Cancer Causes & ControlWijaya et alIllustration
Aromatase Inhibitors vs Tamoxifen and Incident Intracranial Meningioma Risk in Breast Cancer

- Supportive Care in CancerKim et alIllustration
Cutaneous irAEs Linked to Multiorgan Toxicities With Checkpoint Inhibitors

Guidelines & Consensus
- Lung Cancer (Auckland, N.Z.)Soo et alIllustration
Asian Expert Consensus on Early and Locally Advanced NSCLC Management

- BJS openHallet et alIllustration
Consensus on Perioperative Management of Carcinoid Crisis in Neuroendocrine Tumours

- Gynecologic oncologyGrisham et alIllustration
Updated 2026 International Consensus on Low-Grade Serous Ovarian Carcinoma

More news
- Expert review of anticancer therapyKatrina Collins and Liang ChengIllustration
Precision Medicine in Genitourinary Cancers

- HemaSphereOliva et alIllustration
EHA Guidelines and COSMIN Systematic Review on Patient-Reported Outcomes in Ph-Negative MPN Trials

- Journal of Clinical MedicinePark et alIllustration
Tandem ASCT Improves Event-Free Survival in High-Risk Neuroblastoma

- American journal of clinical oncologyKhalid et alIllustration
First-Line EGFR-TKIs With Chemotherapy Improve Survival in EGFR-Mutated NSCLC

- EClinicalMedicinePiñana et alIllustration
EBMT Consensus: Viral CNS Infections After HSCT and CAR T-Cell Therapy

- World Journal of UrologyAbushamma et alIllustration
Urinary Biomarker–Guided Surveillance vs Standard Cystoscopy in NMIBC

- International journal of molecular sciencesTartaglione et alIllustration
Measurable Residual Disease in Multiple Myeloma

- International journal of molecular sciencesLasagna et alIllustration
Infectious Complications and Antimicrobial Resistance Across Cancer Immunotherapies




